Walid A M Elgaher
Overview
Explore the profile of Walid A M Elgaher including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
131
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kurmasheva N, Said A, Wong B, Kinderman P, Han X, Rahimic A, et al.
Nat Commun
. 2024 Dec;
15(1):10698.
PMID: 39702301
No abstract available.
2.
Khalifa H, ElHady A, Liu T, Elgaher W, Filhol-Cochet O, Cochet C, et al.
Eur J Med Chem
. 2024 Nov;
282:117048.
PMID: 39566243
CK2 is a Ser/Thr-protein kinase playing a crucial role in promoting cell growth and survival, hence it is considered a promising target for anti-cancer drugs. However, many previously reported CK2...
3.
Shams A, Bousis S, Diamanti E, Elgaher W, Zeimetz L, Haupenthal J, et al.
Protein Sci
. 2024 Oct;
33(11):e5195.
PMID: 39473025
This study investigates the potential of energy-coupling factor (ECF) transporters as promising anti-infective targets to combat antimicrobial resistance (AMR). ECF transporters, a subclass of ATP-binding cassette (ABC) transporters, facilitate the...
4.
Metelkina O, Konstantinovic J, Klein A, Shafiei R, Fares M, Alhayek A, et al.
Chem Sci
. 2024 Aug;
15(33):13333-13342.
PMID: 39183927
Dual inhibitors of two key virulence factors of , the lectin LecA and the protease LasB, open up an opportunity in the current antimicrobial-resistance crisis. A molecular hybridization approach enabled...
5.
Hammami A, Bardaoui A, Eissa S, Elgaher W, Chtourou R, Messaoud O
Molecules
. 2024 Jun;
29(12).
PMID: 38930902
The current study focused on the design of an extremely sensitive electrochemical sensor of ascorbic acid based on a mixture of NiAlO-NiO nanoparticles that, produced in a single step using...
6.
Kurmasheva N, Said A, Wong B, Kinderman P, Han X, Rahimic A, et al.
Nat Commun
. 2024 May;
15(1):4096.
PMID: 38750019
The presence of heterogeneity in responses to oncolytic virotherapy poses a barrier to clinical effectiveness, as resistance to this treatment can occur through the inhibition of viral spread within the...
7.
Sake S, Zhang X, Rajak M, Urbanek-Quaing M, Carpentier A, Gunesch A, et al.
Nat Commun
. 2024 Feb;
15(1):1173.
PMID: 38332002
Respiratory syncytial virus (RSV) is a common cause of acute lower respiratory tract infection in infants, older adults and the immunocompromised. Effective directly acting antivirals are not yet available for...
8.
Afanasenko A, Wu X, De Santi A, Elgaher W, Kany A, Shafiei R, et al.
Angew Chem Int Ed Engl
. 2023 Oct;
63(4):e202308131.
PMID: 37840425
Deriving active pharmaceutical agents from renewable resources is crucial to increasing the economic feasibility of modern biorefineries and promises to alleviate critical supply-chain dependencies in pharma manufacturing. Our multidisciplinary approach...
9.
Sikandar A, Popoff A, Jumde R, Mandi A, Kaur A, Elgaher W, et al.
Angew Chem Int Ed Engl
. 2023 Jul;
62(40):e202306437.
PMID: 37466921
Even with the aid of the available methods, the configurational assignment of natural products can be a challenging task that is prone to errors, and it sometimes needs to be...
10.
Waqas F, Shehata M, Elgaher W, Lacour A, Kurmasheva N, Begnini F, et al.
PLoS Pathog
. 2023 Jul;
19(7):e1011506.
PMID: 37459366
In addition to antioxidative and anti-inflammatory properties, activators of the cytoprotective nuclear factor erythroid-2-like-2 (NRF2) signaling pathway have antiviral effects, but the underlying antiviral mechanisms are incompletely understood. We evaluated...